2 / 20
Disclosure
Consultancy and academic fees from: Bayer, Almirall,
Lilly, Sanofi, Merck, Astra-Zeneca, Astellas, Hospira,
Celltrion, Pfizer, Merck-Serono, Ferrer, Amgen, Takeda,
Celgene, BIOSIM, Vertex, Kern
Member of the EMA-CHMP 2002-2011. Involvement in
the development of the EMA policy on biosimilars and
evaluation of the MAA of biosimilar medicinal products